What Precia Group does

Precia Group is a Seattle, Washington-based privately held Clinical Research Organization (CRO) and Site Management Organization (SMO) founded in 2020 by Donna Russell, MHA. The company is purpose-built around women's health clinical research across the lifespan, covering reproductive health, pregnancy, menopause, and conditions disproportionately affecting women such as autoimmune and cardiovascular disease. Its core offering is an end-to-end clinical trial services suite — strategic consulting, clinical operations, regulatory strategy from IND through marketing applications, clinical data management, site selection and feasibility, study design and protocol development, KOL/PI engagement, biobanking services, customized site performance management, and medical record abstraction — delivered to pharmaceutical, biotechnology, and medical device sponsors, healthcare start-ups, and community hospitals and clinics. Pricing is quote-based under multi-year contracts and is not publicly disclosed.

The company's principal technical and commercial differentiator is the Precia Network, a first-of-its-kind collaborative CRO model aggregating US and international community and rural hospitals and clinics. The Network is designed to recruit and retain women, minorities, and underserved populations in clinical research at materially higher rates than typical trials — a case study reports 1,600+ women recruited in Year 1 of an observational diagnostic study with 7 of 10 pregnant women agreeing to enroll, 40% African American participation, and 10% Hispanic/Latin participation. Underlying technology is a customized electronic data capture platform and customized medical record abstraction processes, supplemented by partnerships with industry-leading biospecimen storage providers for maternal and neonate biobanking.

Precia's go-to-market is sales-led and enterprise-focused: direct partnership engagement with sponsors, site relationship management through the Precia Network, and strategic consulting for community hospital systems on biobank establishment and FDA Guidance Inclusion Plans. The company is dual-certified as a Women-Owned Small Business (WOSB) by the U.S. SBA and as a Women-Owned Business Enterprise National Council (WBENC) member, conferring preferred-vendor status with diversity-prioritizing procurement organizations. The company is founder-controlled, reports no disclosed funding rounds, no parent company, no subsidiaries, and no acquisitions, and operates from a single Seattle headquarters under a small named senior leadership team.

Name

Precia Group

Legal name

Precia Group

Website

https://preciagroup.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Precia Group is a Seattle-based CRO/SMO founded in 2020 that provides end-to-end clinical trial services to pharmaceutical, biotech, and medical device companies in women's health. Its Precia Network of community hospitals increases diverse representation in clinical research.

Ownership category

akta.pro rank

Product category

Clinical Research Services

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

Keywords

• Clinical research services
• Women's health research
• Site management organization
• Clinical trial management
• Biobanking services

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Organization Services: Comprehensive clinical trial solutions including strategic consulting, clinical operations, regulatory strategy, and clinical data management services for drug and device development targeting women's health. Services span from IND submissions to marketing applications.
2. Site Management Organization Services: Site management services that enhance operational efficiency and ensure high-quality data collection and regulatory compliance across the Precia Network of community and rural research sites.
3. Strategic Consulting Services: Consulting services advising community hospital systems on establishing biobanks and research institutes, as well as FDA Guidance Inclusion Plans for sponsors seeking regulatory compliance.
4. KOL Access and Engagement Services: Access to Precia's vast network of women's health Key Opinion Leaders (KOLs) and Principal Investigators (PIs) for study design consultation, standard of care insights, and market readiness support.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Precia Group is a Clinical Research Organization (CRO) and Site Management Organization (SMO) that delivers end-to-end women's health clinical trial services, including strategic consulting, clinical operations, regulatory strategy, clinical data management, site selection, study design, biobanking, and KOL access. Its proprietary Precia Network of US and international community hospitals and clinics enables clinical research in geographic areas where women receive care, supporting sponsors, sites, and emerging start-ups across the women's health continuum.

Product overview

Precia Group is a dual-certified Women-Owned Small Business and Clinical Research Organization (CRO) / Site Management Organization (SMO) offering a comprehensive suite of clinical research services focused on women's health. The company provides end-to-end clinical trial solutions including Strategic Consulting, Clinical Operations, Regulatory Strategy, Clinical Data Management, Site Selection, Study Design, Biobanking Services, and KOL Access and Engagement. At the core of their model is the Precia Network, a unique community-based research network connecting US and international community hospitals and clinics to increase women's representation in clinical trials. Additional services include Site Management Services, Customized Performance Management tools, and Medical Record Abstraction processes. The company serves pharmaceutical, biotechnical, and medical device companies (Sponsors), research sites, and emerging Start-ups across the women's health continuum including reproductive health, pregnancy, and menopause.

Differentiator

Problem solved

Functional benefit

Brands

• Precia Network: A community-based research model network of US and international community hospitals and clinics engaging women as partners in research

Products and services

• Strategic Consulting

Quantifiable outcome

• 7 of 10 pregnant women agree to enroll in trial
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Academic Medical CenterscoreStrategic or Co-development PartnerPrecia partners with Academic Medical Centers to create new research opportunities for women in the geographic areas where they receive care. These partnerships support maternal and neonate biobank establishment, care plan creation, and global harmonization of maternal cohorts for large-scale multi-omics studies.
• Industry Leading Biospecimen Storage Solutions ProviderscoreTechnology or IntegrationPrecia partners with industry leading biospecimen storage solutions to meet sponsors' specimen short- and long-term banking needs, supporting the establishment of maternal and neonate biobanks for pregnancy cohort research.
• Community Hospitals and Clinics (Precia Network)coreStrategic or Co-development PartnerPrecia Network is a first-of-its-kind collaborative CRO model with community hospitals and clinics, addressing the critical need to increase research capacity at sites with limited regulatory experience, shortage of qualified clinical research staff, and lack of access to experienced Principal Investigators. These partnerships bring clinical trials and health solutions to communities that stand to benefit from them the most.
• Bill & Melinda Gates FoundationminorStrategic or Co-development PartnerCEO Donna Russell previously consulted globally with the Bill & Melinda Gates Foundation and other major funders and NGOs on maternal health research, establishing biobanks and research networks in community settings.
• Seattle Children's Research Institute - Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)minorStrategic or Co-development PartnerCEO Donna Russell previously served as Director of Research at Seattle Children's Research Institute Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), bringing deep expertise in pregnancy outcomes research and biobank harmonization.
• Valley Medical CenterminorStrategic or Co-development PartnerCEO Donna Russell serves on the board of Valley Medical Center, a community hospital affiliated with the University of Washington, demonstrating deep understanding of integrating research into clinical settings for high-quality, diverse, and equitable studies.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Fortrea (LabCorp Drug Development spinoff): Spun off from LabCorp in 2023, Fortrea is a major CRO offering clinical development, patient access, and laboratory services. It is a broad incumbent with similar end-to-end service breadth but no women's health specialization.
• ICON plc: Top-tier global CRO providing Phase I–IV clinical trial services, laboratory services, and consulting. ICON competes for the same pharma/biotech sponsors as Precia but operates at vastly greater scale without a dedicated women's health or community site focus.
• Parexel International: Global CRO with deep therapeutic area expertise including oncology, neuroscience, and rare disease. Parexel is a broad incumbent comparable to Precia in offering strategic consulting through regulatory submission, but at much larger scale.
• Syneos Health: Global biopharmaceutical solutions organization offering clinical development and commercial services. Syneos is a broad incumbent peer with comparable CRO capabilities to Precia but at significantly larger scale and broader therapeutic scope.
• PPD (Thermo Fisher Scientific): Global CRO acquired by Thermo Fisher in 2021, offering comprehensive clinical research and laboratory services. PPD is a broad incumbent that competes with Precia for Phase I–IV sponsor work, particularly with its post-acquisition scale.
• IQVIA: The largest global CRO offering full Phase I–IV clinical research services, real-world evidence, and technology platforms. IQVIA is a broad incumbent Precia competes with for sponsor dollars, but lacks Precia's dedicated women's health specialization and community-site network.

Others

• Clario: Clinical trial endpoint technology and eCOA/ePRO/data management provider. Clario is a technology peer given Precia's customized EDC and data management offering, and would be a partner or substitute depending on sponsor build-vs-buy preference.

Direct peers

• Medpace Holdings: Mid-sized full-service CRO with strong therapeutic specialization across oncology, metabolic disease, and women's health indications. Medpace is a direct peer given its sponsor-focused, full-lifecycle clinical trial model and reputation for operational execution.
• Worldwide Clinical Trials: Mid-sized global CRO focused on Phase II–IV trials with deep therapeutic area expertise in CNS, cardiometabolic, and rare disease. Worldwide is a direct peer given its mid-tier size, sponsor-led model, and therapeutic specialization similar in spirit to Precia's women-health focus.

Emerging players

• ObvioHealth: Digital-first decentralized CRO focused on women's health, pediatrics, and other therapeutic areas. ObvioHealth is an emerging player comparable to Precia in women's health focus and willingness to bring trials into non-traditional/community settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/precia-group

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precia Group